SequelSEC

Polomar Health Services, Inc. PMHS

Pharmaceutical Preparations · CIK 0001265521 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$648.23K
Fiscal year ended 2025-12-31
Operating income
-$10.55M
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

Polomar Health Services, Inc. (PMHS) reported revenue of $648.23K and net income of -$10.70M for the fiscal year ended 2025-12-31. This page shows 4 annual periods of income statement, balance sheet and cash flow figures normalized from Polomar Health Services, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Polomar Health Services, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Revenue$648.23K$58.82K$41.84K$34.53K
Cost of revenue$188.13K$27.92K$4.29KUnavailable
Gross profit$460.10K$30.90K$37.55K$34.53K
Operating income-$10.55M-$1.30M-$440.83K-$181.45K
Net income-$10.70M-$1.34M-$588.00K-$181.12K
Research & developmentUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 27.76Mshares 27.66Mshares 26.12MUnavailable
Pretax incomeUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.39$-0.05$-0.02$0.00
Selling, general & administrative$11.01M$1.33M$478.38KUnavailable
General & administrative$10.94M$1.28M$450.45K$215.98K
Selling & marketing$66.57K$46.00K$27.93KUnavailable

Balance

Polomar Health Services, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Cash & equivalents$132.15K$6.19K$224Unavailable
Total assets$390.04K$9.95M$107.10K$261.48K
Current assets$322.73K$76.81K$12.27K$261.48K
Total liabilities$1.61M$1.35M$151.64K$74.72K
Current liabilities$1.61M$1.34M$102.46K$74.72K
Total equity incl. NCI-$1.22M$8.60M-$44.54K$186.77K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailable
Inventory$93.64K$68.78K$3.46KUnavailable
Accounts receivable$96.94K$1.84KUnavailable$30.00K
GoodwillUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailable

Cash flow

Polomar Health Services, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Operating cash flow-$396.00K-$1.02M-$534.31K-$40.93K
Capital expendituresUnavailable$90.89KUnavailableUnavailable
Investing cash flowUnavailable-$90.89KUnavailableUnavailable
Financing cash flow$521.95K$1.11M$317.50K$266.55K
Net change in cash$125.96K-$2.62K-$216.81K$225.62K
Stock-based compensation$129.64KUnavailableUnavailable$174.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$9.77M$263.28K$5.83KUnavailable

Derived

Polomar Health Services, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Free cash flowUnavailable-$1.11MUnavailableUnavailable
Gross margin71.0%52.5%89.7%100.0%
Operating margin-1627.5%-2209.1%-1053.5%-525.6%
FCF marginUnavailable-1888.1%UnavailableUnavailable
SBC / revenue20.0%UnavailableUnavailable504.0%
Current ratioUnavailable0.06x0.12x3.50x
Revenue YoY growth1002.0%40.6%21.2%Unavailable
Net margin-1650.8%-2280.2%-1405.2%-524.6%
R&D / revenueUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailable154.5%UnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PMHS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-06-01View SEC filing
10-K · Filed 2026-05-06View SEC filing
10-Q · Filed 2025-11-25View SEC filing
10-Q · Filed 2025-08-19View SEC filing
10-Q · Filed 2025-06-30View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.